HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fred Aswad Selected Research

asapiprant

1/2022Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19.
4/2021Eicosanoid signaling as a therapeutic target in middle-aged mice with severe COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fred Aswad Research Topics

Disease

2COVID-19
01/2022 - 04/2021
2Infections
01/2022 - 04/2021
2Neoplasms (Cancer)
12/2021 - 01/2018
2Hemophilia A (Haemophilia)
01/2018 - 10/2016
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2021
1Hypersensitivity (Allergy)
01/2019
1Autoimmune Diseases (Autoimmune Disease)
01/2018
1Autoimmune Hepatitis
10/2006
1Hepatitis
02/2006

Drug/Important Bio-Agent (IBA)

2asapiprantIBA
01/2022 - 04/2021
2EicosanoidsIBA
01/2022 - 04/2021
2VaccinesIBA
04/2021 - 01/2018
2Pharmaceutical PreparationsIBA
04/2021 - 01/2019
2Proteins (Proteins, Gene)FDA Link
01/2018 - 10/2006
2Factor VIII (Coagulation Factor VIII)IBA
01/2018 - 10/2016
1Prostaglandin D2IBA
01/2022
1prostaglandin D2 receptorIBA
01/2022
1Phospholipases (Phospholipase)IBA
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1Phospholipases A2 (Phospholipase A2)IBA
01/2022
1CytokinesIBA
12/2021
1Biological ProductsIBA
12/2021
1Cytarabine (Cytosar-U)FDA LinkGeneric
12/2021
1Prostaglandins DIBA
04/2021
1COVID-19 VaccinesIBA
04/2021
1AntibodiesIBA
01/2019
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
01/2018
1Neutralizing AntibodiesIBA
10/2016
1EpitopesIBA
10/2016
1MitogensIBA
10/2006
1Concanavalin AIBA
10/2006
1ADP Ribose Transferases (ADP Ribosyltransferase)IBA
02/2006
1Adenosine Diphosphate (ADP)IBA
02/2006
1EnzymesIBA
02/2006
1NAD (NADH)IBA
02/2006
1alpha-galactosylceramideIBA
02/2006

Therapy/Procedure

2Immunotherapy
12/2021 - 01/2018
1Therapeutics
01/2018